CLEAR GENE

Clear Gene detects remaining solid tumors using genomics and machine learning. Residual Illness Cancer that persists after therapy is known as residual illness. A succession of technological breakthroughs in residual disease identification has assisted patients with liquid tumors.  To detect a remaining solid tumor, they employed genomics and machine learning.  Patients with solid tumors like breast cancer, on the other hand, have been left behind. Until now, that is. Cancer that persists after therapy is known as residual illness.  Life-changing innovations need an atmosphere that encourages unconventional thinking while still rewarding rigorous product development.  They work on both the high and low end of the innovation spectrum.